Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Distinct glutamatergic projections of the posteroventral medial amygdala play different roles in arousal and anxiety
Ying Li, Yuchen Deng, Yifei Zhang, Dan Xu, Xuefen Zhang, Yue Li, Yidan Li, Ming Chen, Yuxin Wang, Jiyan Zhang, Like Wang, Yufeng Cang, Peng Cao, Linlin Bi, Haibo Xu
Ying Li, Yuchen Deng, Yifei Zhang, Dan Xu, Xuefen Zhang, Yue Li, Yidan Li, Ming Chen, Yuxin Wang, Jiyan Zhang, Like Wang, Yufeng Cang, Peng Cao, Linlin Bi, Haibo Xu
View: Text | PDF
Research Article Neuroscience

Distinct glutamatergic projections of the posteroventral medial amygdala play different roles in arousal and anxiety

  • Text
  • PDF
Abstract

Sleep disturbance usually accompanies anxiety disorders and exacerbates their incidence rates. The precise circuit mechanisms remain poorly understood. Here, we found that glutamatergic neurons in the posteroventral medial amygdala (MePVGlu neurons) are involved in arousal and anxiety-like behaviors. Excitation of MePVGlu neurons not only promoted wakefulness but also increased anxiety-like behaviors. Different projections of MePVGlu neurons played various roles in regulating anxiety-like behaviors and sleep-wakefulness. MePVGlu neurons promoted wakefulness through the MePVGlu/posteromedial cortical amygdaloid area (PMCo) pathway and the MePVGlu/bed nucleus of the stria terminals (BNST) pathway. In contrast, MePVGlu neurons increased anxiety-like behaviors through the MePVGlu/ventromedial hypothalamus (VMH) pathway. Chronic sleep disturbance increased anxiety levels and reduced reparative sleep, accompanied by the enhanced excitability of MePVGlu/PMCo and MePVGlu/VMH circuits but suppressed responses of glutamatergic neurons in the BNST. Inhibition of the MePVGlu neurons could rescue chronic sleep deprivation–induced phenotypes. Our findings provide important circuit mechanisms for chronic sleep disturbance–induced hyperarousal response and obsessive anxiety-like behavior and are expected to provide a promising strategy for treating sleep-related psychiatric disorders and insomnia.

Authors

Ying Li, Yuchen Deng, Yifei Zhang, Dan Xu, Xuefen Zhang, Yue Li, Yidan Li, Ming Chen, Yuxin Wang, Jiyan Zhang, Like Wang, Yufeng Cang, Peng Cao, Linlin Bi, Haibo Xu

×

Figure 2

The effects of chemogenetic excitation of MePVGlu neurons on wakefulness and anxiety-like behavior.

Options: View larger image (or click on image) Download as PowerPoint
The effects of chemogenetic excitation of MePVGlu neurons on wakefulness...
(A) Schematic diagram showing AAV-CaMKIIa-hM3Dq-mCherry/AAV-CaMKIIa-mCherry virus injection and EEG-EMG recordings. (B) Representative images (original magnification, ×10) of c-fos (green), mCherry (red), and DAPI (blue) colocalization in MePVGlu neurons of MePVGlu-hM3Dq-mCherry mice treated with CNO or saline. Scale bar = 500 μm. (C) Three-hour hypnograms following saline or CNO (1 mg/kg) injections into an MePVGlu-mCherry mouse (left) and an MePVGlu-hM3Dq-mCherry mouse (right). (D) Percentages of time spent in each state for MePVGlu-hM3Dq-mCherry mice and MePVGlu-mCherry mice 3 hours after CNO injection. (E) Time spent in each condition 6 hours after injection of saline or CNO (1 mg/kg) into the MePVGlu-hM3Dq-mCherry mice (top) and the MePVGlu-mCherry mice (bottom). (F) Left panel: Representative track plots of MePVGlu-hM3Dq-mCherry mice treated with saline and CNO in open field test (red frame represents the central zone). Right panel: Time spent in the center zone and distance traveled of MePVGlu-hM3Dq-mCherry mice and MePVGlu-mCherry mice. (G) Left panel: Representative heatmaps of MePVGlu-hM3Dq-mCherry mice treated with saline and CNO in elevated plus maze (closed arms on black frames). Right panel: Time spent in open/closed arms of MePVGlu-hM3Dq-mCherry mice and MePVGlu-mCherry mice. Wilcoxon signed rank test or 2-way repeated measures (RM) ANOVA test with Holm-Šídák post hoc comparison for D and E. Two-way RM ANOVA test with Holm-Šídák post hoc for F and G. n = 8 per group. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts